We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Molecular Diagnostics

Image: The Deep Visual Spatial Transcriptomics and Proteomics (DVSTP) strategy integrates high-resolution pathology images with spatial transcriptomics and spatial proteomics to reveal the complex intra-tumor heterogeneity. DVSTP predicts molecular profiles from routine pathology slides, making spatial multi-omics more accessible. Whole–tumor 3D reconstruction reveals that SRSF6 drives immune exclusion and poor clinical outcomes (Photo courtesy of Science Bulletin)

AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

An AI–enabled, 3D spatial multi-omics strategy delineates colorectal tumor architecture and immune infiltration. More...
06 Jun 2026
Image: Graphical abstract (Pandya T, Zagorulya M, Leung MM, et al. Plasma signals of lung tumor promotion for molecular cancer prevention. Cell. 2026. doi:10.1016/j.cell.2026.05.005)

Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

A 14-protein blood signature predicts lung cancer risk up to five years before diagnosis, beyond smoking status. More...
05 Jun 2026
Image: New findings show that circulating tumor DNA testing can guide postoperative chemotherapy and reduce relapse in selected patients (Image credit: Shutterstock)

Circulating Tumor DNA Testing Guides Chemotherapy, Reduces Relapse in Colon Cancer

A ctDNA blood test guides adjuvant chemotherapy in stage II colon cancer and cuts relapse risk. More...
04 Jun 2026
Image: In ALT-positive cancers, researchers found that centromere-associated DNA can be inserted near telomeres at chromosome ends (Image credit: Shutterstock)

Researchers Uncover Distinct Chromosome Signature in Aggresive ALT Cancers

New findings reveal a previously unseen chromosome interaction in alternative lengthening of telomeres positive (ALT+) tumors More...
04 Jun 2026
Image: The Prosigna test provides clinicians and patients with genomic insights to help make more informed breast cancer treatment decisions (Photo courtesy of Veracyte)

Genomic Test Guides Chemotherapy Decisions in Early-Stage Breast Cancer

A new test estimates 10-year distant recurrence and predicts chemotherapy benefit in early HR+ breast cancer to guide treatment. More...
04 Jun 2026
Image: Cancer study findings showed that extensive chromosome loss is more widespread than previously recognized and often linked to harder-to-treat unstable tumors (image credit: Adobe Stock)

Simple Cytogenetic Method Could Improve Classification of ALL Subtypes

Researchers demonstrate evidence of widespread chromosome loss across cancers and a simple method to distinguish similar-looking ALL subtypes. More...
03 Jun 2026
Image: The blood-based assay captures circulating chromatin, cell-free DNA fragments that are largely inaccessible through standard laboratory methods (image credit: Shuttertstock)

Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

A new cfDNA assay captures immune, stromal and tumor signals to monitor immunotherapy response and resistance in sarcoma More...
03 Jun 2026
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Automatic CLIA Analyzer
Shine i6000


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.